UNSPSC 51262305: Ridazolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2R4QO1868Y. European Medicines Agency schedules Ridazolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10302MIG. Ridazolol generally arises in the molecular formula C15H18CL2N4O3.

UNSPSC 51262305 Ridazolol is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The source shows two recent opportunities posted under this code, but neither involves ridazolol specifically. Seminole County, Florida issued IFB60459723LAS on June 30, 2026, to procure naloxone and drug deactivation systems — opioid-reversal and pharmaceutical waste management products, not the antimicrobial compound the code names. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to explore direct-to-manufacturer pharmacy distribution models for prescription fulfillment, which likewise does not map to ridazolol procurement. The code appears to see little recent demand from state and local buyers for the specific pharmaceutical product it describes.

The two opportunities demonstrate a mismatch between the UNSPSC category assignment and actual purchasing intent. Seminole County's naloxone and deactivation-system solicitation targets a specific public-health intervention tied to opioid crisis response, with quarterly deliveries and a two-year term with one-year renewal option; the RFI from Texas HHS pursues a structural shift in pharmacy benefit administration rather than procurement of a named drug product. Neither reflects demand for ridazolol. Without additional recent opportunities tagged to this code and aligned to pharmaceutical active ingredients or antimicrobial products, the code signals low current activity among state and local buyers. Firms evaluating ridazolol sales to state and local health systems should monitor code 51262305 activity or consider whether their target customers classify similar products under different UNSPSC codes within broader pharmaceutical or pharmaceutical-ingredient families.